BR112017018436A2 - biomarcadores para pré-eclâmpsia - Google Patents

biomarcadores para pré-eclâmpsia

Info

Publication number
BR112017018436A2
BR112017018436A2 BR112017018436A BR112017018436A BR112017018436A2 BR 112017018436 A2 BR112017018436 A2 BR 112017018436A2 BR 112017018436 A BR112017018436 A BR 112017018436A BR 112017018436 A BR112017018436 A BR 112017018436A BR 112017018436 A2 BR112017018436 A2 BR 112017018436A2
Authority
BR
Brazil
Prior art keywords
preeclampsia
preeclampsia biomarkers
biomarkers
hemopexin
microglobulin
Prior art date
Application number
BR112017018436A
Other languages
English (en)
Inventor
Åkerström Bo
Göran Gram Magnus
Hansson Stefan
Original Assignee
A1M Pharma Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A1M Pharma Ab filed Critical A1M Pharma Ab
Publication of BR112017018436A2 publication Critical patent/BR112017018436A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4713—Plasma globulins, lactoglobulin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/795—Porphyrin- or corrin-ring-containing peptides
    • G01N2333/805—Haemoglobins; Myoglobins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

a presente invenção se refere ao uso de hemopexina, hemoglobina fetal livre, não ligada à célula e alfa-1-microglobulina como marcadores para a pré-eclâmpsia.
BR112017018436A 2015-03-16 2016-03-16 biomarcadores para pré-eclâmpsia BR112017018436A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201570146 2015-03-16
DKPA201570794 2015-12-03
PCT/EP2016/055619 WO2016146647A1 (en) 2015-03-16 2016-03-16 Biomarkers for preeclampsia

Publications (1)

Publication Number Publication Date
BR112017018436A2 true BR112017018436A2 (pt) 2018-04-17

Family

ID=55586291

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017018436A BR112017018436A2 (pt) 2015-03-16 2016-03-16 biomarcadores para pré-eclâmpsia

Country Status (14)

Country Link
US (1) US20180074070A1 (pt)
EP (1) EP3271727A1 (pt)
JP (1) JP2016173366A (pt)
KR (1) KR20170125975A (pt)
CN (1) CN107430134A (pt)
AU (1) AU2016232309A1 (pt)
BR (1) BR112017018436A2 (pt)
CA (1) CA2977458A1 (pt)
EA (1) EA201791978A1 (pt)
MX (1) MX2017011198A (pt)
SG (1) SG11201706736RA (pt)
TW (1) TW201702383A (pt)
WO (1) WO2016146647A1 (pt)
ZA (1) ZA201705532B (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108776226B (zh) * 2018-04-08 2021-03-19 邓成 晚发型子痫前期快速筛查用试纸和试剂盒
JP2021528476A (ja) * 2018-06-28 2021-10-21 サルアクア ダイアグノスティックス， インコーポレイテッド ハプトグロビン関連タンパク質と関係する組成物および方法
CN109867717A (zh) * 2019-04-01 2019-06-11 山西瑞亚力生物技术有限公司 一种血浆中α1微球蛋白的提取方法
AU2021418225A1 (en) * 2021-01-05 2023-07-13 Public University Corporation Yokohama City University Biomarker for determining fertility, and determining method using same
CN113092777B (zh) * 2021-03-26 2023-11-14 泰达国际心血管病医院 孕早期进行重症子痫前期患者筛查的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX347788B (es) 2007-02-12 2017-05-12 A1M Pharma Ab Diagnosis y tratamiento de preeclampsia.
CN102906568B (zh) 2010-03-24 2014-11-12 普利鲁米那诊断公司 作为先兆子痫早期阶段标志物的HbF和A1M
JP2015519564A (ja) * 2012-05-08 2015-07-09 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ 子癇前症評価を提供するための方法および組成物
EP3567371A1 (en) * 2013-03-15 2019-11-13 Sera Prognostics, Inc. Biomarkers and methods for predicting preeclampsia

Also Published As

Publication number Publication date
AU2016232309A1 (en) 2017-09-28
CA2977458A1 (en) 2016-09-22
MX2017011198A (es) 2018-02-19
KR20170125975A (ko) 2017-11-15
EA201791978A1 (ru) 2018-01-31
WO2016146647A1 (en) 2016-09-22
ZA201705532B (en) 2020-01-29
TW201702383A (zh) 2017-01-16
SG11201706736RA (en) 2017-09-28
US20180074070A1 (en) 2018-03-15
JP2016173366A (ja) 2016-09-29
EP3271727A1 (en) 2018-01-24
CN107430134A (zh) 2017-12-01

Similar Documents

Publication Publication Date Title
CL2016002455A1 (es) Anticuerpos multiespecíficos.
BR112018011089A2 (pt) composições e métodos para a imuno-oncologia
CL2018000778A1 (es) Proteínas de unión a pd-1 y métodos para usarlas
BR112017027764A2 (pt) melhorias de medição para sistemas lte
FR3039060B1 (fr) Coupe menstruelle ergonomique
EP3252468A4 (en) Biological information measurement system
CO7151527A2 (es) Anticuerpos anti-cd79 b e inmunoconjugados
CR20150634A (es) Compuestos heteroaromáticos y su uso como ligandos d1 de dopamina
BR112017018436A2 (pt) biomarcadores para pré-eclâmpsia
BR302013001139S1 (pt) Configuração aplicada em porta-placa indicadora.
DE102016108286A8 (de) Fahrzeuginstrumentengruppe
BR112017013498A2 (pt) composições de inibidor de nitrificação e métodos para a preparação das mesmas
AR095048A1 (es) Proceso electroquímico para el acoplamiento de fenol a anilina
BR112018012313A2 (pt) composições que compreendem 15-hepe e métodos para uso das mesmas
CO2017010143A2 (es) Procesos para preparar fluorocetólidos
AR097668A1 (es) Colorante-polímero
AR096154A1 (es) Colorantes bisazoicos alcoxilados
BR112018006446A2 (pt) composições lubrificantes e métodos para uso das mesmas
IL263423A (en) Aptamer-based index tests
MX2018004005A (es) Ensayo de potencia celular.
BR112017022927A2 (pt) sutiã para teste de estresse
BR112017021850A2 (pt) detecção de isoformas específicas de clusterina
EP3126841B8 (en) Biomarkers for assessing hiv
ES2758084T8 (es) Marcador novedoso para diabetes gestacional
EP3358347A4 (en) MARKER FOR DETERMINING DIABETIC NEPHROPATHY

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired